Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany.
Radiother Oncol. 2009 Dec;93(3):419-23. doi: 10.1016/j.radonc.2009.08.040. Epub 2009 Sep 24.
To investigate the dosimetric benefit of integration of 4D-CT in the planning target volume (PTV) definition process compared to conventional PTV definition using individual margins in stereotactic body radiotherapy (SBRT) of lung tumours.
Two different PTVs were defined: PTV(conv) consisting of the helical-CT-based clinical target volume (CTV) enlarged isotropically for each spatial direction by the individually measured amount of motion in the 4D-CT, and PTV(4D) encompassing the CTVs defined in the 4D-CT phases displaying the extremes of the tumour position. Tumour motion as well as volumetric and dosimetric differences and relations of both PTVs were evaluated.
Volumetric examinations revealed a significant reduction of the mean PTV by 4D-CT from 57.7 to 40.7 cm(3) (31%) (p<0.001). A significant inverse correlation was found for the motion vector and the amount of inclusion of PTV(4D) in PTV(conv) (r=-0.69, 90% confidence limits: -0.87 and -0.34, p=0.007). Mean lung dose (MLD) was decreased significantly by 17% (p<0.001).
In SBRT of lung tumours the mere use of individual margins for target volume definition cannot compensate for the additional effects that the implementation of 4D-CT phases can offer.
研究在立体定向体部放射治疗(SBRT)肺癌中,与使用个体运动幅度的传统计划靶区(PTV)定义相比,将 4D-CT 整合到 PTV 定义过程中的剂量学优势。
定义了两种不同的 PTV:PTV(conv),由螺旋 CT 上的临床靶区(CTV)等向性扩大,扩大幅度为 4D-CT 中个体测量的运动幅度;PTV(4D),包含 4D-CT 相位中显示肿瘤位置极值的 CTV。评估了肿瘤运动以及两者 PTV 的体积和剂量学差异及其关系。
体积检查显示,4D-CT 将平均 PTV 从 57.7 降至 40.7 cm³(31%)(p<0.001),有显著降低。运动向量与 PTV(4D)包含在 PTV(conv)中的幅度之间存在显著的负相关(r=-0.69,90%置信区间:-0.87 和-0.34,p=0.007)。平均肺剂量(MLD)降低了 17%(p<0.001)。
在 SBRT 肺癌中,仅使用个体运动幅度来定义靶区体积不能补偿 4D-CT 相位的实施所带来的额外影响。